Literature DB >> 4998602

An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: double-blind study.

M Ditch, F J Kelly, O Resnick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4998602     DOI： 10.1111/j.1532-5415.1971.tb02623.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  4 in total

1.  The effect of hydergine on the transit time of cerebral circulation in diffuse cerebral insufficiency.

Authors:  B Mongeau
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 2.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  J C Soares; S Gershon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

3.  Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry.

Authors:  B Saletu; J Grünberger; L Linzmayer; P Anderer
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Mitochondrial Protection and Against Glutamate Neurotoxicity via Shh/Ptch1 Signaling Pathway to Ameliorate Cognitive Dysfunction by Kaixin San in Multi-Infarct Dementia Rats.

Authors:  Xiaoqiong Li; Wen Wen; Ping Li; Ying Fu; Hao Chen; Fushun Wang; Yuan Dai; Shijun Xu
Journal:  Oxid Med Cell Longev       Date:  2021-07-09       Impact factor: 6.543
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.